If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test…
The COMPPARE Coordinating Center announced today that the study has enrolled its 1,500th proton prostate cancer patient and has closed enrollment for…
The COMPPARE Coordinating Center announced today that the study achieved 75% enrollment on May 3, 2022. COMPPARE realized both a remarkable…
Study goals, benefits, and other details
More than 45 partner sites across the US
COMPPARE clinicians, researchers, patients, and other stakeholders
For Healthcare providers
Study-specific materials and other information.
Privately and publicly funded clinical studies conducted around the world.
Medical Team sign-in page